Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis
{{output}}
Background: Multiple sclerosis (MS) initiates with a first attack or clinically isolated syndrome (CIS). The importance of an early treatment in MS leads to the search, as soon as possible, for novel biomarkers which can predict ... ...
